21 October 2021 | Features
Combating Counterfeit Drugs in India
Inception- 2018
Location- Bengaluru & US
Founder- Padmakumar Nair (Chief Executive Officer), Shalini V Nair (Chief Technology Officer)
Total team strength- 40
Total funds raised -Rs 45 crore
Investors- Fenice Investment Group, US
Revenue generated since inception- NA
Key Highlights-
Founder Speaks-
"We are currently focusing our efforts in pharmaceutical companies in India as it is a key market for the export of generic drugs and further plan to expand to the European and US markets."
-Padmakumar Nair, Co-founder and Chief Executive Officer, Ennoventure, Bengaluru